Search

everythinglearnresearchcommunity

for

Search:↓

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Pexidartinib often causes liver issues and fatigue, especially in women.

The combination of encorafenib and binimetinib caused few skin issues.

A 7-year-old boy with a brain tumor developed early puberty, which was successfully treated with medication.

Cyclophosphamide severely damages the intestinal lining in rats.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

Different medications improved various PCOS symptoms and quality of life in Pakistani women, but did not significantly help with excessive hair growth.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

The summary does not report the effectiveness of Stanozolol in treating Pityriasis rubra pilaris.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Finasteride blocks progesterone's effect on absence seizures in rats.

Valproic acid can cause dark lines on nails.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Ruxolitinib can help regrow hair in severe alopecia areata.

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

Consider THPP in patients with muscle weakness and low potassium, as it is often underdiagnosed.